Healthcare Reforms Under the IRA: Expanding Access to Care
Healthcare Law Blog
AUGUST 25, 2022
Drugs eligible for negotiation must be FDA-approved for at least 7 years and marketed in conformance with the Federal Food, Drug, and Cosmetic Act. Premiums for Part D plans will be subject to a premium stabilization plan under which they are capped at an increase of 6% annually through 2029. Negotiation-Eligible Drugs.
Let's personalize your content